News About: Pharm. Industry
Pharmaceutical firms staging all-out efforts to boost OTC sales
Influenced by sluggish sales of over-the-counter products, domestic pharmaceutical firms are grappling with their first-quarter sales target by stepping up OTC sales.
To cope with tepid domestic demand, a number of...
Dong-A to launch 9 biological products by 2013
Dong-A Pham plans to launch nine biological drugs by 2013 with hope of acquiring large shares in the global market.
To that end, the company will conduct clinical trials for six biological products to treat various...
SymBio targets cancer patch marketJapanese company SymBio has landed a Korean partner for its novel transdermal patch for chemotherapy-induced nausea, the firm's first patch product with ambitions to steal a siz...
|
Self-regulation sets standards for ethical promotion of medicines
The International Federation of Pharmaceutical Manufacturers & Associations requires all IFPMA member associations and companies to adhere to the provisions of the IFPMA Code, reflecting the minimum standards of the I...
Clevudine is effective in combating hepatitis B virus
Clevudine could offer patients and their physicians an important new disease management option that might reduce the need for further therapeutic intervention after a defined treatment period, said Professor Chu Chung...
Green Cross to conduct Phase I trial for DNA recombinant productGreen Cross Corporation plans to carry out its Phase I study to evaluate a new DNA recombinant drug Hepabig-Gene, which was approved by the Korean Food and Drug Administration.
...
|
Multinational urged to promote third-party deposit system
The lukewarm attitudes of foreign-invested pharmaceutical firms toward the third-party deposit system have been under fire, according to pharmaceutical business sources.
The Korea Pharmaceutical Manufacturers Assoc...
Plavix market heats up
The country's generic makers will be in a fierce race to snatch up a bigger market share of Plavix (clopidogrel bisulfate) as chemically modified drugs developed by Chong Kun Dang and Daewoong have been eligible for n...
Huons launches once-daily sibutramine tablets
Huons said on march 24 it has launched its once-a-day sibutramine tablets (Esrin ) to take on its bigger rivals Hanmi Pharm, Daewoong Pharm and Yuhan Corporation.
The 60 billion won of the sibutramine markets so ...
Large U.S. distributors want to buy medicated plasters from Korea
The large U.S. distribution corporations, including HHC in California, Trusco and Kel, plan to solidifying partnership with Korean drug makers to import Korea's medicated plasters having more competitiveness than reno...
